Bonraybio Co., Ltd.

NT$83.00As of Sun 8 Nov 2026, 12:00 UTC
TWSE:6955Healthcare
Country Taiwan
PE (Fwd) •••
TSR 3Y CAGR 16.31%
Div yield 1.48%
ROE 17.39%
Medical Devices
Beta (5Y) 0.20
PE TTM 23.43
TSR TTM (39.11%)
Mkt cap NT$2.522B
ROIC 99.55%
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$80
(3.24%)
(16.89%)
Hold 0|12|11|4|8
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.91
0.99
1.01
1.09
9.56%
24.22%
17.02%
23.20%
RevenueNT$M
176.1
171.8
174.1
182.4
2.91%
(0.57%)
(4.86%)
0.72%
Peers (US$76.16M)
Cap (US$)
PE
83.85M
—
71.32M
12.80x
76.30M
—
Capital
TTM
5Y
10Y
Leveragex
0.159
(1.318)
(1.174)
EBIT/Intx
0.392
0.319
0.309
Own earn%
(374.35)
(19.91)
(15.02)
Sh yield%
39.34
31.10
28.09
Owners
Insiders/Inst%
4.42
84.87
Short interest%
1.17
SBC / revenue%
3.69
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
21–29
$1 testx
—
Incr. ROIC%
9